184 related articles for article (PubMed ID: 19804461)
1. Content of ecstasy in the Netherlands: 1993-2008.
Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
Tanner-Smith EE
Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
[TBL] [Abstract][Full Text] [Related]
3. mCPP: an undesired addition to the ecstasy market.
Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
[TBL] [Abstract][Full Text] [Related]
4. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
5. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Parrott AC
Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
[TBL] [Abstract][Full Text] [Related]
6. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
Brunt TM; Koeter MW; Niesink RJ; van den Brink W
Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
[TBL] [Abstract][Full Text] [Related]
7. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
[TBL] [Abstract][Full Text] [Related]
8. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
Brunt TM; Niesink RJ; van den Brink W
Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814
[TBL] [Abstract][Full Text] [Related]
9. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
10. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
11. Is online information on ecstasy tablet content safe?
Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
[TBL] [Abstract][Full Text] [Related]
12. Methylone and mCPP, two new drugs of abuse?
Bossong MG; Van Dijk JP; Niesink RJ
Addict Biol; 2005 Dec; 10(4):321-3. PubMed ID: 16318952
[TBL] [Abstract][Full Text] [Related]
13. Instability of the ecstasy market and a new kid on the block: mephedrone.
Brunt TM; Poortman A; Niesink RJ; van den Brink W
J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
[TBL] [Abstract][Full Text] [Related]
14. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
15. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
16. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
van der Gouwe D; Brunt TM; van Laar M; van der Pol P
Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
[TBL] [Abstract][Full Text] [Related]
17. The content of ecstasy tablets: implications for the study of their long-term effects.
Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
[TBL] [Abstract][Full Text] [Related]
18. Electrochemical oxidation of amphetamine-like drugs and application to electroanalysis of ecstasy in human serum.
Garrido EM; Garrido JM; Milhazes N; Borges F; Oliveira-Brett AM
Bioelectrochemistry; 2010 Aug; 79(1):77-83. PubMed ID: 20051327
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ecstasy tablets using capillary electrophoresis with capacitively coupled contactless conductivity detection.
Porto SK; Nogueira T; Blanes L; Doble P; Sabino BD; do Lago CL; Angnes L
J Forensic Sci; 2014 Nov; 59(6):1622-6. PubMed ID: 25039689
[TBL] [Abstract][Full Text] [Related]
20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
